Evrofarma SA (EVROF) — Capital Reinvestment Ratio
Evrofarma SA (EVROF) has a Capital Reinvestment Ratio of 0.41x as of December 2022, meaning it reinvests 0% of its operating cash flow (€1.52 Million) in capital expenditures (€615.00K). Check EVROF goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Evrofarma SA Capital Reinvestment Ratio (2014–2022)
This chart tracks Evrofarma SA's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see EVROF cash flow metrics.
Annual Capital Reinvestment Ratio for Evrofarma SA (2014–2022)
Year-by-year Capital Reinvestment Ratio for Evrofarma SA from 2014 to 2022. See Evrofarma SA free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.84x | €2.44 Million | €2.05 Million | ▲ +35.8% |
| 2020 | 0.62x | €1.46 Million | €904.00K | ▲ +26.0% |
| 2019 | 0.49x | €1.78 Million | €875.00K | ▲ +37.2% |
| 2018 | 0.36x | €2.29 Million | €822.00K | ▲ +37.5% |
| 2017 | 0.26x | €3.11 Million | €810.00K | ▲ +9.3% |
| 2016 | 0.24x | €1.08 Million | €258.00K | ▼ -35.2% |
| 2015 | 0.37x | €1.39 Million | €512.00K | ▼ -47.4% |
| 2014 | 0.70x | €866.00K | €607.00K | — |